Menu

Texas Considers GM Mosquitoes

In an effort to prevent the spread of Zika virus, Harris County officials are in discussions with Oxitec to release insects engineered to produce short-lived offspring.

Mar 28, 2017
Kerry Grens

FLICKR, NIAIDHealth officials in Harris County, Texas, which includes the city of Houston, are weighing the possibility of deploying genetically modified mosquitoes to fend off Zika, the Houston Chronicle reported earlier this month (March 19). These male Aedes aegypti, developed by U.K.-based Oxitec, are designed so that their offspring die young, before they spread disease.

Oxitec has reported success in reducing mosquito populations in field sites in Brazil, Panama, and elsewhere. Yet, a proposal to introduce the insects in Florida was shot down by residents last year and the company is looking for another town in the state to the project.

“It looks like we’re going to do or plan to do some sort of trial initially to test out the system,” Deric Nimmo, principal scientist at Oxitec, told the Houston Chronicle.

“We’re not abandoning the tried-and-true” approaches to mosquito control, Harris County Precinct 4 Commissioner Jack Cagle told the newspaper. “We’re willing to see—What can we add to the tried-and-true that can make this better, especially considering that the tried-and-true has some flaws?” The county will begin sampling mosquitoes this spring to see if any have developed resistance to pesticides.

The US Food and Drug Administration approved the mosquitoes for release in Florida last year, but the Houston Chronicle reported that the Environmental Protection Agency may yet weigh in.

November 2018

Intelligent Science

Wrapping our heads around human smarts

Marketplace

Sponsored Product Updates

Slice® Safety Cutters for Lab Work

Slice® Safety Cutters for Lab Work

Slice cutting tools—which feature our patent-pending safety blades—meet many lab-specific requirements. Our scalpels and craft knives are well suited for delicate work, and our utility knives are good for general use.

The Lab of the Future: Alinity Poised to Reinvent Clinical Diagnostic Testing and Help Improve Healthcare

The Lab of the Future: Alinity Poised to Reinvent Clinical Diagnostic Testing and Help Improve Healthcare

Every minute counts when waiting for accurate diagnostic test results to guide critical care decisions, making today's clinical lab more important than ever. In fact, nearly 70 percent of critical care decisions are driven by a diagnostic test.

LGC announces new, integrated, global portfolio brand, Biosearch Technologies, representing genomic tools for mission critical customer applications

LGC announces new, integrated, global portfolio brand, Biosearch Technologies, representing genomic tools for mission critical customer applications

LGC’s Genomics division announced it is transforming its branding under LGC, Biosearch Technologies, a unified portfolio brand integrating optimised genomic analysis technologies and tools to accelerate scientific outcomes.